Please check with your insurance provider for more information, and for their most up-to-date list of panel doctors.
^Specialists may qualify to be on the Extended Panel (EP). You may enjoy selected panel benefits depending on your policy and riders.
Dr Juanda Hartono is a gastroenterologist at Mount Elizabeth Hospital, Singapore.
His special interests are in inflammatory bowel disease (IBD), general gastroenterology and hepatology and clinical nutrition.
Dr Hartono is currently a visiting senior consultant at the National University Hospital (NUH).
He graduated from the University of North Sumatera, Indonesia and subsequently underwent his internal medicine training at the Universiti Malaya, Malaysia. He moved to NUH and completed his gastroenterology and hepatology specialist training there. He was granted the Academic Medicine Development Award by NUH for inflammatory bowel disease and colorectal cancer and underwent a 1-year advanced fellowship at The Royal London Hospital, UK, where he was also a Joint Advisory Group on GI Endoscopy, UK-certified endoscopist.
During his time at NUH, he served as patient safety officer, clinical director, and IBD lead in the division of gastroenterology and hepatology.
Dr Hartono was an assistant professor at the National University of Singapore, having served as core tutor and regular clinical examiner. He was also a core faculty member of postgraduate specialist training programme in gastroenterology and hepatology and was a member of Singapore board specialist examination committee. He was involved as a faculty member in medical conferences as an invited speaker, chairperson and organising committee.
He served as a reviewer in international medical journals and has published academic papers in peer-reviewed journals.
Curtius, K., Kabir, M., Bakir, I. A., Choi, C. H. R., Hartono, J. L., Johnson, M., East, J. E., Lindsay, J. O., Vega, R., Thomas-Gibson, S., Warusavitarne, J., Wilson, A., Graham, T. A., & Hart, A. (2021). Multicentre derivation and validation of a colitis-associated colorectal cancer risk prediction web tool. Gut, 71(4), 705–715.
Buie, M. J., Quan, J., Windsor, J. W., Coward, S., Hansen, T. M., King, J. A., Kotze, P. G., Gearry, R. B., Ng, S. C., Mak, J. W., Abreu, M. T., Rubin, D. T., Bernstein, C. N., Banerjee, R., Yamamoto-Furusho, J. K., Panaccione, R., Seow, C. H., Ma, C., Underwood, F. E., . . . Li, M. (2023). Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review with Temporal analyses. Clinical Gastroenterology and Hepatology, 21(9), 2211–2221.
Hartono, J. L., Qua, C., & Goh, K. (2010). Non-Erosive reflux Disease (NERD), Symptomatic and asymptomatic erosive reflux disease (ERD): from hypersensitive to hyposensitive esophagus. Digestive Diseases and Sciences, 56(1), 90–96.
Hartono, J. L., Aung, M. O., Dan, Y. Y., Gowans, M., Lim, K., Lee, Y. M., Lee, G. H., Low, H. C., Tan, P. S., Thwin, M. A., Soon, C., Chiu, L., Khoo, M. J., Koay, E., & Lim, S. G. (2013). Resolution of adefovir‐related nephrotoxicity by adefovir dose‐reduction in patients with chronic hepatitis B. Alimentary Pharmacology & Therapeutics, 37(7), 710–719.